Concepedia

James Deeds

JD

Statistics

Publications

20

Citations

3.4K

H-Index

20

Active since

1992

Affiliations

Massachusetts General Hospital(Current)

Millennium Engineering and Integration (United States)

Harvard University

Novartis (United States)

Novartis (Switzerland)

James Deeds is an author at Massachusetts General Hospital specializing in molecular biology, medicine, and life sciences.

Publications per year

1992–2020

20

Publications

20

Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.

Lyn M. Duncan, James Deeds, John Hunter et al. · PubMed · 1998 · 406 citations

, , +17

Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats.

Kyongbum Lee, James Deeds, G V Segre · Endocrinology · 1995 · 362 citations

, , +14

Vascular <i>MAD</i> s: Two novel <i>MAD</i> -related genes selectively inducible by flow in human vascular endothelium

James N. Topper, Jiexing Cai, Yubin Qiu et al. · Proceedings of the National Academy of Sciences · 1997 · 324 citations · Full text

, , +15

Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol

Mariet Lee Varban, Franz Rinninger, Nan Wang et al. · Proceedings of the National Academy of Sciences · 1998 · 307 citations

, , +14

Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development.

Kyongbum Lee, Beate Lanske, Andrew C. Karaplis et al. · Endocrinology · 1996 · 283 citations

, , +17

1–5 of 20